About liberDi
liberDi is a company based in Or Akiva (Israel) founded in 2014. liberDi has raised $1.13 million across 4 funding rounds from investors including European Union and Medimor. liberDi offers products and services including Digital Dialysis Clinic and Intelligent Dialysis Assistant (iDA). liberDi operates in a competitive market with competitors including AWAK, Peripal, Relavo, Simergent and GlomeriaTherapeutics, among others.
- Headquarter Or Akiva, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Liberdi Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.13 M (USD)
in 4 rounds
-
Latest Funding Round
$100 K (USD), Grant
Oct 28, 2021
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of liberDi
liberDi offers a comprehensive portfolio of products and services, including Digital Dialysis Clinic and Intelligent Dialysis Assistant (iDA).
Platform for safe and effective home peritoneal dialysis.
Automated device for ambulatory PD exchanges at home.
Funding Insights of liberDi
liberDi has successfully raised a total of $1.13M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $100 thousand completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in liberDi
liberDi has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Medimor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medimor is engaged in providing manufacturing solutions for medical markets.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for liberDi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by liberDi
Investment portfolio details for liberDi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - liberDi
Detailed financials for liberDi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Liberdi Comparisons
Peer comparison for liberDi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of liberDi
liberDi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AWAK, Peripal, Relavo, Simergent and GlomeriaTherapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops innovative portable digital dialysis devices for healthcare.
|
|
| Locked | Locked | Locked |
Develops innovative home-based devices for peritoneal dialysis treatments.
|
|
| Locked | Locked | Locked |
Development of dialysis devices for kidney failure patients is conducted.
|
|
| Locked | Locked | Locked |
Automated peritoneal dialysis systems are manufactured for home use.
|
|
| Locked | Locked | Locked |
Medical devices for nephropathy and cardiopathy treatments are developed.
|
Detailed competitors of liberDi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Liberdi
Complete news archive for liberDi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about liberDi
liberDi was founded in 2014 and raised its 1st funding round 4 years after it was founded.
liberDi is headquartered in Or Akiva, Israel. It is registered at Or Akiva, Central District, Israel.
Hezkiah Tsoory is the current CEO of liberDi.
liberDi is a funded company, having raised a total of $1.13M across 4 funding rounds to date.
Founded in 2014 in Or Akiva, Israel, LiberDi operates in the medical device sector, focusing on portable automatic peritoneal dialysis systems for end-stage renal disease patients. The flagship product supports bedside catheter installation and addresses catheter-related leaks. Its lightweight and compact design enables patients to conduct dialysis independently. Operations emphasize safe, user-friendly renal care solutions.
liberDi's top competitors include Simergent, Padmaseetha Technologies and Avyantra.
liberDi offers Digital Dialysis Clinic and Intelligent Dialysis Assistant (iDA).
liberDi has 2 investors. Key investors include European Union, and Medimor.